LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 16,481 pages found matching <a href=""></a>- Botox Approved for Migraine
Oct-16-10 On the heels Allergan Inc. pleading guilty to marketing its wrinkle smoother botox for unapproved uses, the Food and Drug Administration has now approved Allergan's product, which is a purified form of the poison botulinum, for chronic migraine headaches. Allergan settled an investigation on October 5th and was ordered by a judge to pay $375 million... - Unum Wins Again, at Least with Their Own
Oct-16-10 Chattanooga, TN While some policyholders may still have issues with how they are treated at the hands of Unum , the people who work for the insurance goliath apparently love to work there. As reported by the October 4th issue of Business Wire , the insurance provider once known as Unum Provident took home top honors for Best Places to Work in the insu... - $2.5 Million Settlement Awarded in First Chinese Drywall Trial
Miami, FL: A $2.5 million settlement has been reached in the first ever Chinese drywall lawsuit to go to trial. The suit, filed by Florida couple Armin and Lisa Seifart, alleged Miami-based Banner Supply Co knowingly sold them defective drywall. Banner was a distributor for Chinese-made Knauff Plasterboard contaminated drywall. The Se... - Toy Giant Mattel Recalls Nearly 11 Million Toys
Sep-30-10 New York, NY With the Christmas consumer rush about to get underway, giant toy manufacturer Mattel has announced a massive defective product recall , of nearly 11 million products sold throughout the US and Canada. The products in question carry the lauded Fisher-Price brand, and were in stores up to and including September, according to a release by t... - Segway Injuries on the Rise: Report
Oct-5-10 Washington, DC The death last month of James W. Heselden underscores a report released around the same time as Heselden's demise that puts the focus on injuries suffered by users of the Segway . Heselden, the British businessman who recently purchased the company that makes the Segway personal transportation devices, was killed on September 26 while app... - Canada Declares BPA a Toxin
Oct-15-10 Ottawa, ON The Canadian government has officially declared the plastic-making compound known as BPA – or bisphenol-A to be toxic, making it the first country in the world to do so. The decision represents the final regulatory step by the government, following a rigourous four-year study which resulted in Health Canada banning BPA from polycarb... - Significant Decision Reached in Redux Lawsuit
Oct-15-10 Cincinnati, OH: A significant decision in a case being watched very closely by regulators, patient advocates and the entire pharmaceutical industry was reached recently regarding an en banc petition made by Wyeth in a Redux (commonly known as fen-phen) lawsuit. Wyeth's en banc petition came after the Sixth Circuit Court of Appeals in August rejecte... - Reglan Tardive Dyskinesia Mis-Diagnosed as Parkinson's Disease
Oct-15-10 Grand Haven, MI: Diane believes she has Tardive Dyskinesia, and has retained an attorney to help in her fight against the makers of Reglan , but timing is crucial to her claim. "At first I was refused representation because I live in Michigan but my California attorney says the rules in that state are different and it looks like I can get involved in... - Race to Replace Warfarin Chases a Potential $20 Billion US Market
Oct-15-10 Washington, DC It's been around for 60 years and is one of the most common, go-to blood thinners prescribed to patients as a means to break up—or ward against—blood clots. But Warfarin , known commercially as Coumadin or Jantoven, is a complex drug that's not easy to get right. Until recently, methods used to determine a patient's suitabilit... - Meridia Diet Drug Pulled from US Market: FDA
Oct-15-10 Washington, DC The manufacturer of Meridia sibutramine has finally decided to pull the diet drug from the market after failing to win the approval of a safety advisory panel affiliated with the US Food and Drug Administration (FDA). The latter actually requested that Abbott Laboratories withdraw the drug, to which Abbott complied. However, the withd... - Judge: Damages in Fosamax Side Effects Case "Excessive"
Oct-15-10 New York, NY A federal judge recently ruled that an $8 million damage award in a case involving Fosamax side effects was "excessive." US District Judge John F. Keenan in Manhattan said that Shirley Boles could either have a new trial or accept a $1.5 million award for the case surrounding Merck & Co.'s osteoporosis drug, according to the Wall S... - Is Byetta's Manufacturer Pushing the Envelope?
Oct-9-10 STOCKHOLM Since the FDA's approval of Byetta (the first commercial product based on GLP-1) in May 2005, manufacturers Amylin Pharmaceuticals and Eli Lilly & Co. have been working hard to ensure that its diabetes drug reaps profits, which is likely a challenge for the giant pharmaceutical company, particularly since Byetta has been associated with... - What Should Patients Do In Light of Avandia Restrictions?
Oct-14-10 San Francisco, CA Following the US Food and Drug Administration's announcement that it was severely restricting use of Avandia , and the European Medicines Agency's announcement that Avandia was being pulled from the market, patients in the US could be forgiven for wondering what they should do next. The move by the Food and Drug Administration (FDA) an... - FDA Says Menaflex Collagen Scaffold Should not have Been Cleared
Oct-14-10 Washington, DC The U.S. Food and Drug Administration (FDA) today announced that an orthopedic device used in the knee should not have been cleared for marketing in the United States. The announcement follows a re-evaluation of the scientific evidence that was undertaken after a September 2009 agency report identified problems in the agency's review of... - Fosamax Caused Physical and Emotional Hardship
Oct-14-10 Detroit, MI "I trusted the profession I was in for all these years but it backfired," says Carole, who worked in clinical nursing for 35 years. "And to add insult to injury, I live in the one state where I can't sue Merck, the maker of Fosamax that caused fractures in both my femurs." Michigan is the only state in the US that has immunity from drug... - Medtronic Settles Sprint Fidelis Lawsuits for $268 Million
Oct-14-10 Minneapolis, MN Three years ago Medtronic, the giant medical devices manufacturer, recalled a series of defibrillation leads prone to cracking and other failures that put the lives of patients at risk—and in some cases, cost heart patients their lives. Today it was announced that Medtronic has agreed to a $268 million settlement to facilitate an e... - Study: Byetta Used With Insulin Glargine Helps Control Glucose
Oct-14-10 Stockholm, Sweden A recent study presented at the European Association for the Study of Diabetes (EASD) in Stockholm showed that Byetta in combination with other drugs could lead to improvements for diabetes patients. The study found that the addition of exenatide, marketed as Byetta, twice daily to type-2 diabetics followed by optimization of insul... - Weight Loss Drug Meridia Pulled From US and Canadian Markets
Oct-8-10 Washington, DC The US Food and Drug Administration (FDA) is recommending against continued prescribing and use of Meridia (sibutramine) because this drug may pose unnecessary cardiovascular risks to patients. The FDA has requested that Abbott Laboratories—the manufacturer of Meridia—voluntarily withdraw this drug product from the Unite... - Proposed $43 Million Settlement in ERISA Plan Class Action
Oct-13-10 Cleveland, OH Participants in an ERISA plan associated with National City Corporation (National City) will benefit from a proposed $43 million settlement in a class action lawsuit alleging those defendants responsible for administering the National City Savings and Investment Plan (Plan) breached their fiduciary duties under ERISA by making imprudent i... - All Marketed Sibutramine Drugs Voluntarily Withdrawn in Canada
Oct-13-10 Ottawa, ON Further to Health Canada's October 8, 2010, communication on the voluntary recall by Abbott Laboratories of Meridia (the brand name for the weight-loss drug sibutramine), Health Canada is updating healthcare practitioners and Canadians with respect to the two generic forms of sibutramine drugs authorized in Canada: Apo-sibutramine and Novo-s...